CCI4EU - Accelerating cancer research and innovation in comprehensive cancer infrastructures

Recordings from CCI4EU 2nd Capacity Buiding Conference

CCI4EU - Accelerating cancer research and innovation in comprehensive cancer infrastructures

Recordings from CCI4EU 2nd Capacity Buiding Conference

Chairs: Maja Cemažar, Mef Nilbert, Johan Van Lint

Introduction
CCI4EU (Comprehensive Cancer Infrastructures for the European Union) is a European project aiming to help Member States and Associated Countries improve or develop their existing or future Comprehensive Cancer Infrastructures (CCIs), by helping develop their research & innovation-related capacities.
 
The CCI4EU project will run over 3 years, it will define and create a Maturity Model with quality indicators, to map the status of CCIs in all Member States and in five Associated Countries. Up to 9 sites have been selected for Deep Dive interventions, with 3 onsite visits to help them build their capacity in particular domains. Along with this, tailored online courses, resources and conferences are being developed to open up the capacity building to a wider audience, with the overall aim of contributing to the Horizon Europe Mission of ensuring that 90% of eligible cancer patients have access to Comprehensive Cancer Infrastructures by 2030.
 
The Conference Accelerating cancer research and innovation in comprehensive cancer infrastructures was held in Brussels, Belgium, on 9 and 10 April 2025 and all interventions were recorded and are now available via these pages (to access the material, participants must register to the online course, login to the e-ESO platform and click on the PLAY buttons inside the programme). The event gave individuals and teams from developing CCIs direction in helping them build their capacity and develop their infrastructures. 
 
The gap between research findings and clinical implementation poses a significant challenge in healthcare. Bridging this gap is essential to ensure that the latest evidence is incorporated into patient care effectively. This conference was aimed at professionals involved in translational research, clinical trialists, directors of science and hospital leaders.

Learning Objectives
- Understand the importance of capacity building in research and innovation.
- Learn how to develop/improve biobanking, registries and screening programmes.
- Identify the ways to bring research findings into clinical settings.
- Enhance collaboration between stakeholders and other research centres.
- Explore real-world case studies and examples of successful/unsuccessful of ongoing research, innovation and patent cases.
 
Official language
The material is provided in English. Translations are not provided, but English subtitles can be found in the videos.
 
Registration
Registration to the course is free but mandatory. 
 
Certificate of attendance
Participants will be issued a certificate of attendance once they have completed a minimum attendance of 75% of the entire course. An online evaluation questionnaire must be completed in order to receive the certificate that will be issued by email. The evaluation questionnaire will appear in the right-hand column of the course page when participants have completed 75% of the course.
 
Organising secretariat
Sonia Bulgarelli: sbulgarelli@eso.net
Francesca Marangoni: fmarangoni@eso.net
Sarah Jennie Goldman: sgoldman@eso.net
 
09/04/2025 08:30

Welcome & Introduction

Maja Cemazar (SI) Mef Nilbert (SE) Johan Van Lint (BE)

09/04/2025 08:40

National research collaborations

08:40

The Belgian example

Johan Van Lint (BE)
09:00

Discussion


09/04/2025 09:10

Screening

09:10

EU regulation and the new approach to cancer screening

Urska Ivanus (SI)
09:30

Lecture on lung cancer screening

Miroslav Samarzija (HR)
09:40

Discussion


09/04/2025 10:30

Biobanking

10:30

Best practices from IARC

Zisis Kozlakidis (FR)
10:50

European Research Infrastructures: Key contributors to advancing cancer research and innovation

Manuela Pausan (AT)
11:10

Discussion


09/04/2025 11:30

Collaboration in research

11:30

What does EORTC expect from a CCI to collaborate?

Gaetan de Schaetzen (BE)
11:50

Leveraging real-world data in multinational collaborations to improve clinical practice and quality of care

Tarec Christoffer El-Galaly (DK)
12:05

Discussion


09/04/2025 12:25

Cancer registries

12:25

IARC role in creating synergies

Ariana Znaor (FR)
12:45

Role of the cancer registries in clinical quality

Giske Ursin (NO)
13:05

Discussion

10/04/2025 08:30

Experience of extending capacity in (translational) research

08:30

The Czech Republic experience

Aleksi Sedo (CZ)
08:50

The Slovenian experience

Maja Cemazar (SI)
09:10

Discussion


10/04/2025 09:30

Data

09:30

Implications of the development of the European Health Data Space on cancer data

Magdalena Rosinska (PL)
09:50

Clinical data to be used for research purposes

Alberto Traverso (IT)
10:00

Discussion


10/04/2025 10:50

How to help early/mid-career researchers? How to build a career structure that will attract and retain a good researcher?

10:50

The example of Bulgaria

Assia Konsoulova (BG)
11:05

The example of Italy

Alberto Traverso (IT)
11:20

The example of Belgium

Deb Vansteenwegen (BE)
11:35

Discussion


10/04/2025 12:00

Closing remarks

Maja Cemazar (SI) Johan Van Lint (BE)
Alberto Traverso profile photo
Alberto Traverso

IRCCS San Raffaele Hospital, Department of Artificial Intelligence, Milano, IT

Aleksi Sedo profile photo
Aleksi Sedo

Prague 2, CZ

Ariana Znaor profile photo
Ariana Znaor

IARC, International Agency for Research on Cancer, Scientist Cancer Surveillance, CS 90627 69366 LYON, FR

Assia Konsoulova profile photo
Assia Konsoulova

Deb Vansteenwegen profile photo
Deb Vansteenwegen

KU Leuven, HR Director, Leuven, BE

Gaetan de Schaetzen profile photo
Gaetan de Schaetzen

EORTC, European Organisation for Research and Treatment of Cancer, Belgium, BE

Giske Ursin profile photo
Giske Ursin

Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, NO

Johan Van Lint profile photo
Johan Van Lint

Leuven Cancer Institute (LKI), Cellular & Molecular Medicine Dpt., Leuven, BE

Magdalena Rosinska profile photo
Magdalena Rosinska

Maria Sklodowska-curie National Cancer Institute, Digital Medicine Centre, Warsaw, PL

Maja Cemazar profile photo
Maja Cemazar

Institute of Oncology Ljubljana, Head of Research and Education, Ljubljana, SI

Manuela Pausan profile photo
Manuela Pausan

Biobanking and Biomolecular Resources Research Infrastructure – European Research Infrastructure Consortium, BBMRI-ERIC, Graz, AT

Mef Nilbert profile photo
Mef Nilbert

Lund University, Dept. Oncology, Institute for Clinical Sciences, Lund, SE

Miroslav Samarzija profile photo
Miroslav Samarzija

Clinical Hospital Center Zagreb, Department of Pulmonary Diseases, Zagreb, HR

Tarec Christoffer El-Galaly profile photo
Tarec Christoffer El-Galaly

Aarhus University Hospital, Department of Clinical Medicine, Aalborg, DK

Urska Ivanus profile photo
Urska Ivanus

Institute Of Oncology Ljubljana, Cervical Cancer Screening Department, Ljubljana, SI

Zisis Kozlakidis profile photo
Zisis Kozlakidis

International Agency for Research on Cancer, Head, Laboratory Services and Biobank Group, Lyon, FR